VentureBeat October 17, 2024
In the evolving field of bioinformatics, staying current is a challenge. For MiLaboratories, the challenge was creating software called Platforma.bio, which not only simplifies the complex analysis of immunogenomic data for researchers, but furthers the technology critical for drug discovery, especially in the field of mRNA vaccines and oncovaccines.
The recent launch of Platforma software is accompanied by the April announcement of partnerships with Miltenyi Biotech, whose robust production and commercialization capabilities will fast-track the adoption of full cycle next generation therapies for patients.
Jürgen Schmitz, managing director at Miltenyi Biotec, stated in an April press release: “We are thrilled to partner with MiLaboratories, a company that shares our commitment to advancing human health. Their RNA kits technology for...
Today's Sponsors
Today's Sponsor